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Abstract
Introduction—Colorectal cancer (CRC) is the second most commonly diagnosed cancer in 
Puerto Rico (PR). Given the lack of information on cancer screening behavior, we identified 
factors associated with CRC screening among adults aged ≥ 50 years in PR.
Methods—Age eligible adults who participated in the PR- Behavioral Risk Factor Surveillance 
System (BRFSS) in 2008 were included in the analysis (n=2,920). Weighted prevalence of fecal 
occult blood test (FOBT) within two years and of Sigmoidoscopy/Colonoscopy examination 
within five years before the interview were estimated and logistic regression models were used to 
assess factors associated with these CRC screening practices.
Results—Overall 8.2% (95% CI 7.1%-9.3%) of the participants had had the FOBT within the 
past two years, 39.8% (95% CI 37.7%-41.9%) had sigmoidoscopy/colonoscopy examination 
within 5 years and 46.7% (95% CI= 44.5%-48.8%) had ever had any type of CRC screening. 
Factors positively associated to CRC screening in multivariate analyses included older age, higher 
education, and having had a routine check-up in the past year. Gender, body mass index, and other 
relevant covariates evaluated were not associated to screening behavior.
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Conclusions—Prevalence of CRC screening in PR during 2008 was below the goals established 
by Healthy People 2010 (50.0%) and 2020 (70.5%). We provide the first population-based 
estimates of CRC screening prevalence and correlates in a US predominantly Hispanic population. 
Low adherence to CRC screening may result in late stage at diagnosis and poorer disease 
outcomes. Public health efforts should focus on the promotion of CRC screening and early 
detection.
Introduction
Colorectal cancer (CRC) is the third most common cause of cancer death worldwide (1). In 
Puerto Rico, CRC is the second most commonly diagnosed cancer in both males and 
females, accounting for 14.0% of all cancers diagnosed in both genders from 2005-2009 (2). 
The incidence and mortality trends of CRC have been shown to be increasing in Puerto 
Rico, particularly among males (Annual percent change [APC]incidence= 2.6%, APCmortality= 
3.8%), contrary to declining patterns observed among other racial/ethnic groups in the 
United States (3); this pattern highlights a clear health disparity for this populaiton.
The United States Preventive Services Task Force (USPSTF) guidelines recommend regular 
screening for CRC, in adults, starting at age 50 years and continuing until age 75 years, by 
any of the following regimens: 1) annual fecal occult blood testing (FOBT), 2) 
sigmoidoscopy examination every 5 years combined with fecal occult blood testing every 3 
years, or 3) screening colonoscopy at intervals of 10 years (4). In the United States, despite 
these recommendations, and although significant increasing trends have been documented in 
the proportion of adults up-to-date with CRC screening from 2000 to 2010, 2010 screening 
rates, according to the National Health Interview Survey, were still below (58.6%) (5) the 
Healthy People 2020 target of 70.5% (6). Although data from the Behavioral Risk Factor 
Surveillance Survey (BRFSS) also supports this increase in CRC screening in the United 
States and Puerto Rico, particularly in the use of sigmoidoscopy/colonoscopy examination 
(Figure 1) (7), the use of these procedures remains low, especially among Hispanics (5, 
8-10).
Although CRC screening has been shown to improve treatment outcomes and survival, to 
our knowledge, no population-based study has previously analyzed factors associated to 
CRC screening practices in Puerto Rico, a predominantly Hispanic population. This 
information is essential for the development of targeted interventions and early detection 
programs in the island. This study aimed to determine the prevalence and factors associated 
to CRC screening among the population aged ≥50 years living in Puerto Rico.
Methods
We conducted a secondary data analysis of the Puerto Rico Behavioral Risk Factor 
Surveillance System (PR-BRFSS) conducted in 2008. PR-BRFSS is an annual landline 
telephone-based survey designed to measure chronic diseases and behavioral risk factors in 
the adult population 18 years of age or older in Puerto Rico. Initiated in 1996, the PR-
BRFSS is conducted by the PR Department of Health in collaboration with the Centers for 
Disease Control and Prevention (CDC) using a representative data sampling frame for 
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Puerto Rico. The survey provides data that could be compared across participants; which 
includes 50 states, the District of Columbia, Guam, the Virgin Islands, and Puerto Rico (11). 
PR-BRFSS data are recognized as a vital component of the public health monitoring system 
for the adult residents of Puerto Rico. In addition, the data are used for planning, evaluating 
and developing public health programs and initiatives for Puerto Rico's adult population. 
PR-BRFSS data collection instrument is administered by trained interviewers and has an 
average duration of 17 minutes. Foreigners living in Puerto Rico are also included as part of 
the survey. For this analysis, we included the 2,920 (65.3% of total sample) adults aged ≥50 
years out of the 4,475 adults who participated in the survey that year and that had complete 
information on CRC screening practices. The majority of age-eligible participants (>96%) 
responded to the questions of CRC screening. The Institutional Review Board of the 
University of Puerto Rico Medical Sciences Campus approved this study.
The three outcome variables of interest for this analysis were the proportion of people who 
had 1) had a FOBT within two years before the interview, 2) a sigmoidoscopy/colonoscopy 
examination within the five years before the interview, and 3) a combined variable that 
assessed use of FOBT within two years or sigmoidoscopy/colonoscopy within five years of 
the interview. Covariates of interest included demographic characteristics, such as gender, 
age in years, marital status, educational attainment, annual household income, health care 
coverage, and employment status. Clinical characteristics included body mass index (BMI), 
routine checkup in the past year, and perceived general health status. Lifestyle 
characteristics included current smoking status (yes/no), heavy alcohol consumption 
(consuming for than 1 [women] or 2 [men] alcoholic beverages per day), binge drinking 
(consuming more than 4 [women] or 5 [men] alcoholic beverages on a single occasion in the 
past 30 days, [yes/no]), and leisure-time physical activity in the past 30 days.
We performed the statistical analysis using SAS version 9.2 (SAS Institute, Inc, Cary, North 
Carolina). We first described the study sample according to demographic, clinical, and 
lifestyle characteristics. Then we assessed the relationship between CRC screening 
behaviors and specific covariates using Wald Chi-Square Test. Two-sided significance level 
was established at p<0.05.
We estimated the prevalence odds ratios (OR) and their 95% confidence intervals (CI) to 
determine the magnitude of the association between the specific factors and each CRC 
screening behavior. To further assess these relationships, we constructed a multivariable 
logistic regression model for each of the three study outcomes. For each CRC screening 
outcome, we included the variables at least marginally associated with the outcome (P < 
0.10) in the bivariate analyses in the respective multivariable logistic regression model. In 
addition, given its relevance in the literature, we also controlled all models for gender and 
educational attainment. We used the Hosmer and Lemeshow Goodness-of-Fit Test and 
residual analyses to evaluate the models. We tested for interactions using the Likelihood 
ratio (LR) test (12). All data were weighted using post-stratification methodology in which 
the sample was adjusted using 2008 population data (based on Census 2000 estimates) by 
gender, age and health region to represent Puerto Rico's population.
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Approximately 58% of the participants were 50-64 years of age, 54.4% were females, and 
63% had more than high-school education. Also, 27.2% were employed, 95.4% reported 
having health care coverage, 46.5% reported to be in good or excellent general health and 
88.1% had a routine checkup in the previous year (Table 1).
Overall, 8.2% (95% CI= 7.1%-9.3%) of adults had had a FOBT within the past two years; 
39.8% (95% CI= 37.7%-41.9%) had sigmoidoscopy/colonoscopy examination within five 
years; 42.3% (95% CI= 40.3%-44.4%) had either of the recommended CRC screening tests 
within these time periods (Table 2); and 46.7% (95% CI= 44.5%-48.8%) reported ever 
having had any type of CRC screening.
In the bivariate analysis, having had an FOBT test within 2 years was significantly (p<0.05) 
associated with age, marital status, employment status, and routine checkup in the past year 
(Table 2). Having had a sigmoidoscopy/colonoscopy examination within 5 years was 
significantly (p<0.05) associated with age, education, marital status, employment status, 
health care coverage, smoking, perceived general health status and routine checkup in the 
past year. Finally, the analysis for any CRC screening test (FOBT or sigmoidoscopy/
colonoscopy combined within the defined time periods) showed that the associations were 
similar to the sigmoidoscopy/colonoscopy outcome. Sex, BMI, binge drinking and physical 
activity were not associated to the prevalence of any of the CRC screening tests evaluated. 
Household income was excluded from multivariate analysis given the number of individuals 
(n=435, 14.4%) with missing information on this variable.
The multivariable logistic regression model for FOBT showed that people aged 65-75 ( : 
1.89, 95% CI=1.34-2.67) and those aged older than 75 years ( : 1.79, 95% CI=1.18-2.72) 
were more likely to have had an FOBT within the past two years compared with people aged 
50-64 years. Participants who had less than high school ( : 0.79, 95% CI=0.51-0.99) 
were less likely to have had an FOBT than those with higher educational level. Finally, 
people who reported a routine checkup in the past year had higher odds of having been 
screened with FOBT, however this association was marginally significant ( : 1.71, 95% 
CI=1.00-2.92) (Table 3).
According to the sigmoidoscopy/colonoscopy multivariate logistic regression model, people 
aged 65-75 ( : 1.65, 95% CI=1.35-2.03) and those >75 years ( : 2.24, 95% 
CI=1.73-2.91) had significantly higher odds of having had the sigmoidoscopy/colonoscopy 
examination within five years than those aged 50-64 years. Participants who had completed 
high school ( : 0.66, 95% CI=0.54-0.81) and those with less than high school ( : 0.39, 
95% CI=0.31-0.48) had significantly lower odds of having sigmoidoscopy/colonoscopy 
examination than those with more than high school education. Employed individuals ( : 
0.55, 95% CI=0.44-0.68) also had lower odds of having sigmoidoscopy/colonoscopy than 
those unemployed. Finally, people who reported a routine checkup in the past year ( : 
2.56, 95% CI=1.90-3.46) had higher odds of having been screened as compared to those 
who had not had a routine checkup. Smoking, education, marital status and health-care 
coverage were not associated to this outcome in multivariate analyses (p>0.05).
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The third multivariate logistic regression model for any CRC screening test (FOBT or 
sigmoidoscopy/colonoscopy combined) showed that the factors associated to this outcome 
were similar to those associated to sigmoidoscopy/colonoscopy examination in multivariate 
analysis (Table 3). No significant interactions were found in any of the previous three the 
models, and all of them showed to have a good fit (p>0.05).
Discussion
In 2004, premature CRC related deaths accounted for 11.7% ($7.5 million) of the total 
productivity loss in Puerto Rico, making it the second most costly cancer in this population 
(13). This issue is of concern as CRC is highly preventable and can be diagnosed early. 
Correlates of cancer screening practices help describe and explain how CRC screening is 
used in the population, information that is of great relevance for the development of CRC 
prevention and control strategies. This study provides the first population-based estimates of 
CRC screening prevalence and describes its correlates in Puerto Rico, a predominantly 
Hispanic subpopulation of the United States. Our results demonstrate that less than half 
(42.3%) of the population aged ≥ 50 years in Puerto Rico in 2008 reported undergoing CRC 
screening test within the USPSTF recommended time intervals. This is below the prevalence 
of CRC screening in adults aged 50 to 75 years living in the United States in 2008 (62.9%) 
(10) and in 2010 (58.6%) (5), and below the Healthy People 2010 (50%) (14) and 2020 
goals (70.5%) (6). Similar results are observed when we limit our prevalence estimate to 
people aged 50 to 75 years in Puerto Rico (40.1%, 95% CI=37.8%-42.4%). Our result is 
consistent with racial/ethnic disparities in CRC screening that exist in the United States, 
with lowest rates observed among Hispanics (5,8-10). In 2008, more non-Hispanics (59.8%) 
reported having had lower endoscopy (sigmoidoscopy or colonoscopy) within the past 10 
years compared with Hispanics (45.8%); estimates were also higher for non-Hispanic 
Whites (59.8%) and Blacks (56.6%) (10). Meanwhile, recent data from the 2010 NHIS have 
also shown that CRC screening in the United States during this period was lower among 
Hispanics (46.5%) than among non-Hispanics (59.9%) (5). Our results also show that Puerto 
Ricans have lower adherence rates to CRC screening compared with Hispanics living in 
New York (15). In 2008, 14.4% of Hispanics, 17.9% of Blacks, and 19.3% of non-Hispanic 
Whites in New York reported FOBT within the past two years, compared with only 8.2% of 
Puerto Ricans in the current study. Similarly, 59.1% of Hispanics in New York self-reported 
to have had sigmoidoscopy or colonoscopy examination within five years, compared with 
39.8% of the participants in our study.
Screening for CRC reduces mortality by allowing detection of cancer at earlier and more 
treatable stages (16). FOBT screening has been shown to reduce CRC mortality by 
18%-33% in randomized, controlled trials (17-18); and screening with more sensitive 
FOBT, flexible sigmoidoscopy, colonoscopy, or combinations of these tests also reduce the 
burden of CRC (19). Although the prevalence of advanced colorectal neoplasia (adenomas 
≥1 cm and/or advanced histology) among screening colonoscopy cohorts has been shown to 
be lower in Puerto Rican than that reported for Hispanics in the United States (20), the lower 
adherence rates to CRC screening observed in Puerto Rico may result in late stage diagnosis, 
higher mortality, and, thus, poorer disease outcomes in this population (3). Efforts must be 
made to increase the prevalence of CRC screening in the Puerto Rican population, 
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particularly among men, who have exhibited increasing CRC incidence and mortality rates 
(3), and among underserved populations identified in this study. For example, and consistent 
with other studies in the United States (5,21), older individuals in Puerto Rico were more 
likely to be screened for CRC than younger individuals. This is of concern as although 
current screening guidelines include people aged 50-64 years, our results support that this 
group is not properly benefiting from screening. Also of interest is the fact that although 
current USPSTF guidelines recommend to continue screening until the age of 75 years, a 
high prevalence of CRC screening was observed among adults aged older than 75 years in 
Puerto Rico. This evidences that physicians in Puerto Rico are using this test upon discretion 
after this age.
Higher educational attainment and having a routine checkup in the past year were also 
associated with a greater likelihood of being screened for CRC in our study population, a 
finding that is consistent with earlier studies (5,9,21-22). This last result is also consistent 
with a previous study that documented that routine check-up in the past year was also 
positively associated to cervical cancer screening in women in Puerto Rico (23). These 
associations suggest that opportunistic screening is occurring as part of these regular 
interactions of patients with the health care system. Also consistent with this finding, 
previous studies have in fact reported that lack of physician discussion was responsible for 
not being current with screening (24) and that one-on-one patient interactions with practice 
staff, patient reminders, and system level interventions improve CRC screening (25). 
Meanwhile, employed individuals were less likely to have ever had an FOBT or a 
sigmoidoscopy/colonoscopy or to have had been screened with sigmoidoscopy/colonoscopy 
within the past five years than those unemployed. This is consistent to results in the United 
States (9) where retired and out of work persons have been shown to be more likely to have 
had an FOBT within the past year and/or colonoscopy/sigmoidoscopy examination within 
the preceding 5 years. Despite employed individuals are more likely to have a health 
insurance, the time commitments required to prepare for and perform CRC screening tests 
might be a barrier. Furthermore, 6.5% of employed individuals in our sample did not have 
health insurance, a factor that could also influence the observed result. In our study, no 
gender differences were seen in CRC screening. This result is consistent with the nearly 
identical proportions of men (58.5%) and women (58.8%) reported being up-to-date in CRC 
screening in the 2010 NHIS survey (5). Meanwhile, our results of no association between 
BMI and FOBT are consistent with previous data from the 2001 BRFSS performed in the 
United States (26). Nonetheless, contrary to our results, this study performed in the United 
States by Heo and colleagues found that overweight and obese men (class I) were 
significantly more likely to have been screened with sigmoidoscopy in the past 5 years than 
their normal weight counterparts, while obese women (class I and II) were less likely to 
undergo screening, suggesting that BMI may be associated with CRC screening behavior in 
different ways between genders (26).
In the United States, the improvement of CRC screening utilization has occurred in the 
context of expanding Medicare coverage (27-28). Altough most of our study sample had 
health care coverage (95.4%), contrary to data in the United States (5,22), in Puerto Rico, 
having health insurance coverage was not associated with CRC screening test in this study. 
Given the low adherence rates of CRC screening observed in our study, this result suggests 
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that despite health care coverage, many persons in Puerto Rico are not complying with CRC 
screening guidelines. In the US, lack of physician's recommendation to perform the 
corresponding tests is one of the most common barriers among persons who reported no 
CRC testing (22). Given that this information is not available in the BRFSS database, future 
studies in Puerto Rico should explore the barriers to physician recommendation such as 
insurance coverage, dealing with other urgent medical problems, prior patient refusal of 
screening, physician forgetfulness, lack of reminders, and inadequate patient tracking 
systems (29). Furthermore, these studies should evaluate if differences in screening practices 
exist between those with private and those with government-based health care coverage. 
This is of relevance, as for example, in the United States, Medicaid coverage has been 
associated with lower screening rates (9). All this information will help elucidate if it is 
patient's behavior and/or physician/health-care system barriers that most influence CRC 
screening practices.
Our study has several limitations. The response rate for the PR-BRFSS 2008 was 70.2%, 
and although response rate of questions related to CRC screening was high (>96%), this 
non-response may introduce selection bias in our study. However, response rates in Puerto 
Rico for 2008 were much higher than those in the overall United States BRFSS for the same 
year (median=53.3%) (30). Also, self-reported information of participants could have 
introduced information bias. In addition, because the BRFSS is a telephone-based survey, it 
is unable to survey those who reside in households without telephone access. Consequently, 
the above data may not be generalizable to the entire adult Puerto Rican population aged 
≥50 years. Finally, although differences in CRC screening by socioeconomic status and 
other related indicators have been reported in previous studies in the United States (21, 31), 
our study could not evaluate this variable in multivariate analysis given the high percentage 
of individuals with missing data. Nonetheless, this study provides the first population-based 
estimates of CRC screening prevalence and an understanding of how these practices vary 
across demographic, clinical, and lifestyle characteristics in the Puerto Rican population. 
Future studies should further evaluate how social determinants of health may be related to 
CRC screening behavior. In addition, as delineated by the Cancer Control Plan for Puerto 
Rico (32), it is important to increase knowledge about CRC cancer screening and early 
detection among the Puerto Rican population with particular emphasis on high-risk 
geographic areas and high-risk populations (i.e. uninsured, low-educational level, rural 
communities, undocumented immigrants, and handicapped populations). Population-based 
programs, such as the CDC's Colorectal Cancer Control Program, that target underserved 
populations should be implemented in this population (33).
In conclusion, our study found a low prevalence of use of CRC screening methods in Puerto 
Rico in 2008 that was below screening rates in the United States and Healthy People 2010 
and 2020 recommendations. This finding has public health implications as this low 
adherence to CRC screening may result in late stage at diagnosis and poorer disease 
outcomes, and thus have an impact on CRC morbidity and mortality. In addition, main 
correlates of underutilization of CRC screening included being aged 50-64 years, having low 
educational attainment, being employed and not having had a routine clinical check-up in 
the past year. Results from this study should be used for the development of targeted 
intervention efforts in Puerto Rico aimed at reducing CRC disparities in this population. 
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These interventions should be promoted through the Cancer Control Coalition and the 
Colorectal Cancer Coalition of Puerto Rico; and should focus on the promotion of screening 
practices among these identified under-screened populations. Furthermore, CRC prevention 
and education in Puerto Rico will be necessary at all levels, from the healthcare providers to 
the general population, to effect change.
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Weighted percentage of adults aged 50+ who have ever had a sigmoidoscopy or 
colonoscopy and who have had a blood stool test within the past two years in the US and 
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Table 1
Demographic characteristics and medical history of persons aged ≥ 50 years, Behavioral 
Risk Factor Surveillance System (BRFSS) Puerto Rico, 2008
Characteristic
All Respondents
n % (95% CI)
Age group (years) (N=2,920)
 50 –64 1,688 57.8 (55.8-59.8)
 65 –75 764 26.2 (24.5-27.9)
 >75 468 16.0 (14.6-17.4)
Gender (N=2,920)
 Male 1,331 45.6 (43.4-47.7)
 Female 1,589 54.4 (52.3-56.6)
Education level (N=2,916)
 < High School 1,078 37.0 (35.0-39.0)
 High School Graduate 753 25.8 (23.9-27.7)
 > High School 1,085 37.2 (35.1-39.3)
Marital status (N=2,912)
 Married/Cohabitating 1,923 66.0 (64.1-67.9)
 Divorced/Separated 393 13.6 (12.2-14.9)
 Widowed 453 15.5 (14.3-16.8)
 Single 143 4.9 (4.0-5.8)
Employment status (N=2,920)
 Employed 794 27.2 (25.1-29.3)
 Not employed 459 15.7 (14.1-17.3)
 Retired 604 20.7 (19.1-22.3)
 Homemaker 1063 36.4 (34.4-38.4)
Household income (N=2,485)
 ≤ $14,999 1,234 49.7 (47.3-52.0)
 $15,000 - $34,999 875 35.2 (32.9-37.5)
 $35,000 - $49,999 178 7.2 (5.8-8.5)
 ≥ $50,000 198 8.0 (6.6-9.4)
Have any health care coverage (N=2,916)
 Yes 2,781 95.4 (94.5-96.3)
 No 135 4.6 (3.7-5.5)
Perceived general health status (N=2,905)
 Good to Excellent 1,352 46.5(44.4-48.7)
 Fair to Poor 1,553 53.5(51.3-55.6)
Routine checkup in the past year (N=2,827)
 Yes 2,491 88.1 (86.6-89.6)
 No 336 11.9 (10.4-13.4)
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Characteristic
All Respondents
n % (95% CI)
Body mass index (BMI) (N=2,733)
 Underweight/Normal 816 29.9 (27.9-31.8)
 Overweight 1,148 42.0 (39.8-44.2)
 Obese 769 28.1 (26.1-30.2)
Heavy alcohol consumption (N=2,875)
 Yes 475 16.5 (14.9-18.2)
 No 2400 83.5 (81.8-85.2)
Binge drinking (N=2,870)
 Yes 43 1.5 (1.0-2.1)
 No 2827 98.5 (98.0-99.1)
Current smoking status (N=2,919)
 Yes 252 8.6 (7.4-9.9)
 No 2667 91.4 (90.1-92.6)
Leisure-time physical activity (N=2,920)
 Yes 1380 47.3 (45.1-49.4)
 No 1540 52.7 (50.6-54.9)
Abbreviations: CI, confidence interval.
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Table 3
Multivariate logistic regression models of factors associated to CRC Screening tests 
among persons ≥ 50 years, BRFSS PR, 2008
Predictor
FOBT within two years Sigmoidoscopy/Colonoscopy within 5years FOBT within two years or 
Sigmoidoscopy/Colonoscopy 
within 5 years
 (95%CI)a  (95%CI)a  (95%CI)a
Gender
 Female 0.88 (0.66-1.19) 1.10 (0.92-1.30) 1.10 (0.93-1.30)
 Male 1.00 1.00 1.00
Age in years
 50-64 1.00 1.00 1.00
 65-75 1.89 (1.34-2.67) 1.65 (1.35-2.03) 1.69 (1.38-2.06)
 >75 1.79 (1.18-2.72) 2.24 (1.73-2.91) 2.11 (1.64-2.71)
Education Level
 Less than High School 0.79 (0.51-0.99) 0.39 (0.31-0.48) 0.66 (0.53-0.80)
 High School 0.94 (0.43-2.09) 0.66 (0.54-0.81) 0.42 (0.34-0.51)
 More than High School 1.00 1.00 1.00
Marital status
 Divorced/Separated 0.94 (0.43-2.09) 0.73 (0.47-1.13) 0.74 (0.48-1.13)
 Widowed 1.11 (0.55-2.24) 0.88 (0.57-1.38) 1.04 (0.68-1.60)
 Married/Cohabitating 1.60 (0.75-3.42) 1.25 (0.84-1.84) 1.22 (0.84-1.79)
 Single 1.00 1.00 1.00
Employment status
 Yes 1.10 (0.55-2.24) 0.55 (0.44-0.68) 0.63 (0.51-0.77)




1.39 (0.87-2.20) 1.51 (0.97-1.34)
 No 1.00 1.00
Perceived general health status
 Fair to Poor
NA
1.17 (0.99-1.39) 1.14 (0.96-1.34)
 Good to Excellent 1.00 1.00
Routine checkup past year
 Yes 1.71 (1.00-2.92) 2.56 (1.90-3.46) 2.33 (1.76-3.10)




1.03 (0.76-1.40) 1.09 (0.84-1.47)
 No 1.00 1.00
Abbreviations: FOBT, fecal occult blood test; CI, confidence interval; NA, not applicable.
a
Significant p-value: p< 0.05
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